Improved patients satisfaction, adherence and health-related quality of life with Deferasirox (Exjade®) in β-thalassemia patients previously receiving other iron chelation therapies / J.B. Porter, M. Athanasioux Metaxa, D.K. Browden, J. Troncy, D. Habr, G. Domokos, B. Roubert, D. Rofail, A. Gater, J.F. Baladi, M.D. Cappellini. - In: BLOOD. - ISSN 0006-4971. - 114:22(2009 Nov), pp. 980-981. ((Intervento presentato al 51. convegno ASH annual meeting tenutosi a New Orleans nel 2009.
Improved patients satisfaction, adherence and health-related quality of life with Deferasirox (Exjade®) in β-thalassemia patients previously receiving other iron chelation therapies
M.D. CappelliniUltimo
2009
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.